Audentes Therapeutics (BOLD) Technical (Analysis) Reports Audentes Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Audentes Therapeutics (BOLD)
Technical Analysis Report for USA stock BOLD Audentes Therapeutics. Dated: 14 Mar 2025 Updated Daily. Stock trades under Health Care Deals in Biotechnology Biological Products No Diagnostic Substances in USA stock exchange
If you are looking for Tomorrow's Movement Predictions for USA stock BOLD Audentes Therapeutics then click here. or read Experts views on Audentes Therapeutics or Forecast & share price targets of Audentes Therapeutics
Audentes Therapeutics Opened at 1.61 and Closed at: 1.68, which is 3.57% of previous session's close. It moved within a range of 1.60 and 1.68
The session was a Bullish session with an average volume of 38500, which is -130.91% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the mid term trend of the stock remains negative and in a downtrend.
- Even though the stock has shown an up move, but the long term trend of the stock remains negative and in a downtrend.
Support for tomorrow is 1.64 and resistance for tomorrow is 1.72
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 1.63, 1.57 resistance for tomorrow's hourly charts is 1.71, 1.73
10 Day SMA for Audentes Therapeutics (BOLD) is 1.68 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Audentes Therapeutics (BOLD) is 1.82 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Audentes Therapeutics (BOLD) is 2.16 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 2.53 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Audentes Therapeutics is 3.42 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Audentes Therapeutics is at 1.82 and 200 DMA is at 3.42, while 50 DMA and 100 DMA are at 2.16 and 2.53 respectively
Audentes Therapeutics (BOLD) moving average of 20 SMA is at 1.82 and 20 EMA is at 1.82
| Date | Closing Price | 20 SMA | 20 EMA |
| 14 Fri Mar | 1.68 | 1.82 | 1.82 |
| 13 Thu Mar | 1.62 | 1.85 | 1.84 |
| 12 Wed Mar | 1.70 | 1.88 | 1.86 |
| 11 Tue Mar | 1.60 | 1.9 | 1.88 |
| 10 Mon Mar | 1.63 | 1.93 | 1.91 |
| 07 Fri Mar | 1.69 | 1.97 | 1.94 |
Audentes Therapeutics (BOLD) moving average of 50 SMA is at 2.16 and 50 EMA is at 2.13
| Date | Closing Price | 50 SMA | 50 EMA |
| 14 Fri Mar | 1.68 | 2.16 | 2.13 |
| 13 Thu Mar | 1.62 | 2.18 | 2.15 |
| 12 Wed Mar | 1.70 | 2.2 | 2.17 |
| 11 Tue Mar | 1.60 | 2.22 | 2.19 |
| 10 Mon Mar | 1.63 | 2.25 | 2.21 |
| 07 Fri Mar | 1.69 | 2.27 | 2.23 |
Audentes Therapeutics (BOLD) moving average of 100 SMA is at 2.53 and 100 EMA is at 2.68
| Date | Closing Price | 100 SMA | 100 EMA |
| 14 Fri Mar | 1.68 | 2.53 | 2.68 |
| 13 Thu Mar | 1.62 | 2.54 | 2.7 |
| 12 Wed Mar | 1.70 | 2.55 | 2.72 |
| 11 Tue Mar | 1.60 | 2.57 | 2.74 |
| 10 Mon Mar | 1.63 | 2.58 | 2.76 |
| 07 Fri Mar | 1.69 | 2.59 | 2.78 |
Audentes Therapeutics (BOLD) moving average of 200 SMA is at 3.42 and 200 EMA is at 4.08
| Date | Closing Price | 200 SMA | 200 EMA |
| 14 Fri Mar | 1.68 | 3.42 | 4.08 |
| 13 Thu Mar | 1.62 | 3.46 | 4.1 |
| 12 Wed Mar | 1.70 | 3.5 | 4.13 |
| 11 Tue Mar | 1.60 | 3.54 | 4.15 |
| 10 Mon Mar | 1.63 | 3.59 | 4.18 |
| 07 Fri Mar | 1.69 | 3.63 | 4.21 |
Conmed Corporation has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Conmed Corporation, about 14.04% more returns!
Audentes Therapeutics has performed better than Sensus Healthcare in short term. Holding Audentes Therapeutics could be a better choice for now!
Rhythm Pharmaceuticals has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Rhythm Pharmaceuticals, about 8.95% more returns!
Radius Health has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Radius Health, about 126.08% more returns!
Audentes Therapeutics has performed better than Pulse Biosciences in short term. Holding Audentes Therapeutics could be a better choice for now!
Puma Biotechnology has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Puma Biotechnology, about 36.06% more returns!
Neogen Corporation has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Neogen Corporation, about 7.48% more returns!
Nucana Plc has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Nucana Plc, about 1.23% more returns!
Krystal Biotech has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Krystal Biotech, about 34.86% more returns!
Insmed Inc has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Insmed Inc, about 14.47% more returns!
Clearside Biomedical has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Clearside Biomedical, about 5.96% more returns!
Cara Therapeutics has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Cara Therapeutics, about 22.17% more returns!
Astrazeneca Plc has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Astrazeneca Plc, about 24.12% more returns!
Ascendis Pharma has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Ascendis Pharma, about 18.32% more returns!
Array Biopharma has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Array Biopharma, about 9.01% more returns!
Ani Pharmaceuticals has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Ani Pharmaceuticals, about 26.78% more returns!
Aceto Corporation has performed better than Audentes Therapeutics in short term. You could have earned much better returns by investing in Aceto Corporation, about 0.79% more returns!
Audentes Therapeutics Technical analysis of indicators
Price action analysis of Audentes Therapeutics (BOLD) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Audentes Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Audentes Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Audentes Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a SELL signal for Audentes Therapeutics in short term and SELL signal is strong!
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Audentes Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.67 and Audentes Therapeutics BOLD stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Audentes Therapeutics BOLD stock. Volume based technical analysis of Audentes Therapeutics BOLD stock is negative.
Audentes Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for USA stock BOLD Audentes Therapeutics These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And BOLD Experts View which covers a lot of information including buying and selling signals
BOLD future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Audentes Therapeutics or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Audentes Therapeutics (BOLD) Technical (Analysis) Reports Audentes Therapeutics ["Technical Analysis"] Reports -USA Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- USA Screeners
- USA Daily Screener
- USA Weekly Screener
- USA Monthly Screener
- Support & Resistance
- USA Shares Near Support
- USA Shares Near Resistance